Investing

Big Pharma Stocks Eli Lilly, AbbVie and Pfizer Share Q3 Results

Major pharmaceutical players Eli Lilly (NYSE:LLY), AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) reported mixed Q3 results, with each company facing distinct market forces, ranging from supply issues to financial constraints. In its latest quarterly report, released on Wednesday (October 30), Eli Lilly missed on sales expectations for Zepbound, its popular weight-loss drug, and Mounjaro, its diabetes...
Read more

Ashburton Mineralisation Expands as Project Delivers Wide and High-grade Uranium Drill Results

Piche Resources Limited (ASX: PR2) (“Piche” or the “Company”) is pleased to announce drilling results from a further eight holes at its Ashburton uranium project in Western Australia. Results to date highlight the potential for both high grade and broad zones of uranium mineralisation. HIGHLIGHTS ADD003 has delivered the widest intersection recorded to date with...
Read more

A Guide to Investing in Physical Gold (Updated 2024)

Gold is known as an attractive safe-haven investment and has been used to store wealth during volatile times through history. It has interesting currency-like tendencies, and retains its purchasing power better than paper currencies. What physical gold product is best to buy? Physical gold investors are generally looking for items that are 0.999 fine. Most...
Read more

10 Top Oil-producing Countries (Updated 2024)

In recent years, the global oil market has been impacted significantly by COVID-19 disruptions, price wars between oil-producing nations, Russia’s war in Ukraine and the conflicts in the Middle East. Just as oil demand was rebounding as COVID-19 lockdowns eased worldwide, pushing prices higher, Russia’s aggressive war against Ukraine set in, sending oil skyrocketing. However,...
Read more

Cardiex September 2024 Quarter Update

Cardiex Limited (ASX:CDX) (the “Company”) is pleased to report its activities during the September quarter 2024. Highlights: Manufacturing of the initial 8,000 CONNEQT Pulse units commenced with the expected arrival of units in the USA late-November/early December. Pulse waitlist now exceeds 20,000 with activities now focused on sales conversion. Completed clinical validation study of wearable...
Read more